Is the business good?
How good a business is PLSE?
Pulse Biosciences, Inc. keeps −10392% of every revenue dollar as operating profit, against 5.8% for the median Medical Instruments & Supplies name.
−10392%
Operating margin · Medical Instruments & Supplies median 5.8% · 12 months to Q1 2026
- R&D as % of revenue
- 6258%
R&D as % of revenue
- Gross margin
- −21%
Gross margin
| Year | Operating margin |
|---|---|
| FY2020 | −43829% |
| FY2021 | −4444% |
| FY2022 | −8294% |
| FY2025 | −21983% |
Details›
- Gross margin12 months to Q1 2026
- −21%
- Operating margin12 months to Q1 2026
- −10392%
- Net margin12 months to Q1 2026
- −9929%
- Free cash flow margin
- −7390%
- R&D as % of revenue
- 6258%
- Revenue, trailing twelve months
- $751K
- Free cash flow, trailing twelve months
- −$55M
- Net income, trailing twelve months
- −$75M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Medical Instruments & Supplies
Ranks #15 of 27 by Smart Score